Literature DB >> 10973764

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

.   

Abstract

This document was developed by a consensus conference initiated by Kristian Thygesen, MD, and Joseph S. Alpert, MD, after formal approval by Lars Rydén, MD, President of the European Society of Cardiology (ESC), and Arthur Garson, MD, President of the American College of Cardiology (ACC). All of the participants were selected for their expertise in the field they represented, with approximately one-half of the participants selected from each organization. Participants were instructed to review the scientific evidence in their area of expertise and to attend the consensus conference with prepared remarks. The first draft of the document was prepared during the consensus conference itself. Sources of funding appear in Appendix A. The recommendations made in this document represent the attitudes and opinions of the participants at the time of the conference, and these recommendations were revised subsequently. The conclusions reached will undoubtedly need to be revised as new scientific evidence becomes available. This document has been reviewed by members of the ESC Committee for Scientific and Clinical Initiatives and by members of the Board of the ESC who approved the document on April 15, 2000.* Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973764     DOI: 10.1053/euhj.2000.2305

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  262 in total

1.  To define is divine.

Authors:  J S Alpert
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

2.  Was it a heart attack? Troponin measurement is not straightforward.

Authors:  Eric S Kilpatrick
Journal:  BMJ       Date:  2002-05-18

3.  Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice.

Authors:  P O Collinson; P J Stubbs; A-C Kessler
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

4.  Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population.

Authors:  Ruth Frikke-Schmidt; Anne Tybjærg-Hansen; Greg Dyson; Christiane L Haase; Marianne Benn; Børge G Nordestgaard; Charles F Sing
Journal:  Int J Epidemiol       Date:  2014-10-30       Impact factor: 7.196

5.  Low risk of rebound events after a short course of clopidogrel in acute TIA or minor stroke.

Authors:  O C Geraghty; N L M Paul; A Chandratheva; P M Rothwell
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

6.  Myocardial infarction: redefined or reinvented?

Authors:  H Dargie
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

7.  Changing the diagnostic criteria for myocardial infarction in patients with a suspected heart attack affects the measurement of 30 day mortality but not long term survival.

Authors:  C Packham; D Gray; C Weston; A Large; P Silcocks; J Hampton
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

8.  Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction.

Authors:  J L Ferguson; G J Beckett; M Stoddart; S W Walker; K A A Fox
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

9.  Computerized vectorcardiography telemetry: a new device for continuous multilead ST-segment monitoring of ambulatory patients. A preliminary report.

Authors:  Bjarne Linde Nørgaard; Claus Sørensen; Thomas Larsen; Kristian Thygesen; Mikael Dellborg
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

10.  Cardiac complications of chemotherapy: role of biomarkers.

Authors:  Alessandro Colombo; Maria T Sandri; Michela Salvatici; Carlo M Cipolla; Daniela Cardinale
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.